A Look At Sumitomo Chemical (TSE:4005) Valuation After Its Rebound In Annual Earnings

Why Sumitomo Chemical's Latest Earnings Matter For Investors Sumitomo Chemical Company (TSE:4005) just reported full year earnings showing higher net income and earnings per share even as sales declined, helped by foreign exchange gains and contributions from Agro & Life Solutions and ICT & Mobility Solutions. See our latest analysis for Sumitomo Chemical Company. The stock has pulled back 3.66% on a 1-day share price return to ¥600.8 after its earnings release, but a 32.98% year to date share price return and 81.34% 1-year total shareholder return suggest momentum has been building as investors reassess earnings quality, currency sensitivity and recent moves such as the planned Koei Chemical share exchange. If Sumitomo Chemical's rebound has caught your eye, this could be a good moment to look at other opportunities. Consider using our screener of 34 power grid technology and infrastructure stocks for potential long term themes tied to infrastructure and materials demand. The market reaction has been strong, yet the stock still trades only slightly below the latest analyst price target and appears to carry a significant intrinsic discount. This raises the question: is this a genuine opportunity, or is future growth already priced in? Most Popular Narrative: 2% Overvalued The most followed narrative pegs Sumitomo Chemical's fair value at ¥589.7, slightly below the last close of ¥600.8. This implies only a modest premium and puts the focus squarely on the earnings and margin story behind that figure. Recovery in profitability across key segments (Agro & Life Solutions, Essential & Green Materials, ICT & Mobility Solutions) reflects improved operational efficiency, product mix optimization, and R&D-driven new product launches (e.g., Orgovyx, Gemtesa, INDIFLIN), supporting the potential for higher long-term revenue and net margins. Read the complete narrative. Analysts are baking in steady top line, slightly slimmer margins, and a richer future earnings multiple, all filtered through a 7.9% discount rate. This raises the question of which growth, profitability and valuation assumptions need to align for that fair value to hold up. Result: Fair Value of ¥589.7 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are clear pressure points, including weaker petrochemicals margins and rising inventories in Agro & Life Solutions, that could challenge the earnings and valuation narrative investors are watching. Find out about the key risks to this Sumitomo Chemical Company narrative. Another View: Earnings Power Versus Market Multiple Analysts see Sumitomo Chemical as 2% overvalued at ¥589.7 based on their earnings model, yet the stock trades at a P/E of 16.3x versus a JP Chemicals average of 14.2x and a fair ratio of 20.3x. That gap hints at both upside potential and re rating risk. Which side of that trade are you on? See what the numbers say about this price — find out in our valuation breakdown. TSE:4005 P/E Ratio as at May 2026Next Steps If the mix of risks and rewards here feels finely balanced, do not wait for the crowd to decide for you. Review the full breakdown of 3 key rewards and 3 important warning signs. Looking For More Investment Ideas? If Sumitomo Chemical is already on your radar, do not stop there. The market is full of other stocks that could better fit your risk and return preferences. Target long term compounding potential by reviewing companies flagged as 19 high quality undervalued stocks with solid earnings support and room for sentiment to improve. Strengthen your income stream by scanning 41 dividend fortresses that combine higher yields with business models focused on sustaining regular payouts. Get ahead of the crowd by checking the screener containing 55 high quality undiscovered gems where strong fundamentals have yet to attract wide market attention. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for Free